Blue Jet Health

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0KBH01020
  • NSEID: BLUEJET
  • BSEID: 544009
INR
582.00
-7.4 (-1.26%)
BSENSE

Aug 04, 03:30 PM

BSE+NSE Vol: 16.79 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Corona Remedies
Marksans Pharma
P & G Health Ltd
Viyash Scientifi
Akums Drugs
Sudeep Pharma
Strides Pharma
Shilpa Medicare
Sanofi Consumer
Concord Biotech
Blue Jet Health

Why is Blue Jet Healthcare Ltd ?

1
High Management Efficiency with a high ROE of 22.58%
2
The company is Net-Debt Free
3
Poor long term growth as Net Sales has grown by an annual rate of 5.42% and Operating profit at 4.70% over the last 5 years
4
The company has declared Negative results for the last 3 consecutive quarters
  • NET SALES(Latest six months) At Rs 527.78 cr has Grown at -24.08%
  • PAT(Latest six months) At Rs 142.60 cr has Grown at -29.15%
  • ROCE(HY) Lowest at 24.16%
5
With ROE of 17.3, it has a Very Expensive valuation with a 8.1 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -26.02%, its profits have fallen by -34.5%
6
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 2.91% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -26.02% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Blue Jet Health should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Blue Jet Health for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Blue Jet Health
-26.02%
-0.53
49.54%
Sensex
-3.2%
-0.24
13.59%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.42%
EBIT Growth (5y)
4.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.85
Tax Ratio
25.57%
Dividend Payout Ratio
6.82%
Pledged Shares
0
Institutional Holding
9.75%
ROCE (avg)
39.16%
ROE (avg)
22.58%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
47
Industry P/E
103
Price to Book Value
8.10
EV to EBIT
43.40
EV to EBITDA
39.39
EV to Capital Employed
10.41
EV to Sales
12.06
PEG Ratio
NA
Dividend Yield
0.19%
ROCE (Latest)
26.31%
ROE (Latest)
17.27%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
NET SALES(Q)

At Rs 293.11 cr has Grown at 23.8% (vs previous 4Q average

PBT LESS OI(Q)

At Rs 90.71 cr has Grown at 37.5% (vs previous 4Q average

PAT(Q)

At Rs 78.26 cr has Grown at 26.3% (vs previous 4Q average

-11What is not working for the Company
NET SALES(Latest six months)

At Rs 527.78 cr has Grown at -24.08%

PAT(Latest six months)

At Rs 142.60 cr has Grown at -29.15%

ROCE(HY)

Lowest at 24.16%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.79 times

Loading Valuation Snapshot...

Here's what is working for Blue Jet Health

Net Sales - Quarterly
At Rs 293.11 cr has Grown at 23.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 236.83 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 90.71 cr has Grown at 37.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 65.97 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 78.26 cr has Grown at 26.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 61.96 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Blue Jet Health

Debtors Turnover Ratio- Half Yearly
Lowest at 2.79 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio